PHATHOM PHARMACEUTICALS, INC. Public Float
PHATHOM PHARMACEUTICALS, INC. (PHAT) had Public Float of $555.50 million as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $555.50M.
- 2023-06-30: Entity Public Float $470.40M; Entity Public Float as first filed $526.00M.
- 2022-06-30: Entity Public Float $198.00M.
- 2021-06-30: Entity Public Float $684.20M.
| Period end | Entity Public Float | Entity Public Float as first filed |
|---|---|---|
| 2025-06-30 | $555.50M 10-K · filed 2026-02-26 | |
| 2023-06-30 | $470.40M 10-K · filed 2025-03-06 | $526.00M 10-K · filed 2024-03-07 |
| 2022-06-30 | $198.00M 10-K · filed 2023-02-28 | |
| 2021-06-30 | $684.20M 10-K · filed 2022-03-01 | |
| 2020-06-30 | $552.30M 10-K · filed 2021-03-30 | |
| 2019-10-31 | $366.40M 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 |